Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction-Reference-Cited by-同舟云学术

Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction

Published:2007-09-30 Issue:11 Volume:8 Page:1246-1254
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Kaufmann Daniel E,Kavanagh Daniel G,Pereyra Florencia,Zaunders John J,Mackey Elizabeth W,Miura Toshiyuki,Palmer Sarah,Brockman Mark,Rathod Almas,Piechocka-Trocha Alicja,Baker Brett,Zhu Baogong,Le Gall Sylvie,Waring Michael T,Ahern Ryan,Moss Kristin,Kelleher Anthony D,Coffin John M,Freeman Gordon J,Rosenberg Eric S,Walker Bruce D

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni1515.pdf

Reference46 articles.

1. Greenwald, R.J., Freeman, G.J. & Sharpe, A.H. The B7 family revisited. Annu. Rev. Immunol. 23, 515–548 (2005).

2. Chen, L. Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4, 336–347 (2004).

3. Watts, T.H. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23, 23–68 (2005).

4. Barber, D.L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687 (2006).

5. Day, C.L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350–354 (2006).

Cited by 450 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors in infectious disease;Immunological Reviews;2024-09-09

2. Making a Monkey out of Human Immunodeficiency Virus/Simian Immunodeficiency Virus Pathogenesis: Immune Cell Depletion Experiments as a Tool to Understand the Immune Correlates of Protection and Pathogenicity in HIV Infection;Viruses;2024-06-17

3. Immune restoration by TIGIT blockade is insufficient to control chronic SIV infection;Journal of Virology;2024-06-13

4. The role of immune checkpoint inhibitors in the development and treatment of infectious processes;Journal of Clinical Practice;2024-04-17

5. SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals;Nature Communications;2024-04-09